Beta Bionics Regulatory Approval
Beta Bionics received FDA clearance for Mint, its next-generation patch pump featuring a reusable and disposable architecture and smartphone control. The company also submitted a 510(k) application for its 3D Intelligence insulin dosing algorithm, which is expected to power its future automated insulin delivery platforms.
“We believe that our next-generation AID platform, consisting of Mint 3D and iLet 3D, will represent a transformational advancement for people living with diabetes, subject to regulatory clearance by the FDA.”
Sean Saint, President & CEO of Beta Bionics